<DOC>
	<DOCNO>NCT01098630</DOCNO>
	<brief_summary>This clinical trial study patient , physician , nurse factor associate entry onto clinical trial finish treatment patient primary recurrent uterine , endometrial , cervical cancer . Determining patient make decision participate clinical trial may help doctor plan clinical trial patient willing participate satisfy decision participate .</brief_summary>
	<brief_title>Patient , Physician , Nurse Factors Associated With Entry Onto Clinical Trials Finishing Treatment Patients With Primary Recurrent Uterine , Endometrial , Cervical Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine specific , modifiable factor relative patient , physician , nurse , clinical trial design predict enrollment non-enrollment onto GOG therapeutic trial patient primary recurrent invasive cancer uterine corpus cervix . II . To determine Functional Comorbidity Index independent predictor enrollment GOG clinical trial correlate performance status . SECONDARY OBJECTIVES : I . To determine , multivariate analysis , whether distribution patient GOG clinical trial entry status category ( i.e. , enrol , enrol eligible , eligible ) varies demographics economic status patient , patient ' beliefs/concerns interaction physicians/family friend , nurse ' physician ' beliefs/concerns interaction patient . II . To determine whether patient ' beliefs/concerns interaction associate patient , nurse , physician demographic . III . To determine whether physician ' beliefs/concerns interaction associate patient physician demographic . IV . To perform descriptive analysis regard factor associate completion treatment analysis Treatment Review Form . OUTLINE : This multicenter study . Patients assign 1 2 group . GROUP I ( limited participation ) : Patients complete questionnaire baseline . GROUP II ( full participation ) : Patients complete Patient Registration Survey Patient Questionnaire baseline . At baseline , patient ' medical record information collect ; site complete Functional Comorbidity Index ; physician , nurse , study coordinator complete follow-up questionnaire . Staff complete treatment review form treatment 7 month study registration .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<criteria>Meets 1 follow criterion : Patients pathologically confirm diagnosis primary recurrent invasive cancer uterine cervix uterine corpus ( stage ) Further treatment indicate Treatment must take place GOG institution patient enrol A GOG physician , nurse , study coordinator one patient describe Any GOG performance status Meets 1 follow criterion : Willing able complete assist completion 2 questionnaire limited medical history , treatment detail , demographic data collect Patients speak write English ( assist interpreter ) Willing limited medical history , treatment detail , demographic data collect ( Patient ) No patient refuse treatment No concurrent treatment GOG treatment trial Prior participation GOG treatment trial allow</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>